Related Experiment Video

Updated: Aug 19, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

[Ineffectiveness of platelet transfusions in the course of thrombocytopenia of central origin. Work Group coordinated

F Norol1

  • 1Centre de Transfusion Sanguine, Hôpital Henri-Mondor, Créteil.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|January 1, 1995
PubMed

Insights

Platelet transfusions often fail in central thrombocytopenia due to immune issues, patient status, and poor preparation quality. Prevention strategies, focusing on fresh, compatible platelets and avoiding alloimmunization, are key to effective treatment.

Area of Science:

  • Hematology
  • Immunology
  • Transfusion Medicine

Context:

  • Thrombocytopenia of central origin presents challenges in transfusion efficacy.
  • Platelet transfusions are a critical supportive therapy for various hematological conditions.
  • Understanding transfusion failure is vital for optimizing patient care.

Purpose:

  • To identify reasons for platelet transfusion inefficacy in central thrombocytopenia.
  • To develop evidence-based recommendations for therapy and prevention.
  • To critically review existing literature on platelet transfusion outcomes.

Summary:

  • Inefficacy stems from three primary factors: immunological conflict (anti-HLA alloimmunization), patient's clinical status, and suboptimal quality of platelet preparations (e.g., prolonged storage).
  • Recommendations are tailored based on urgency, cause of refractoriness, clinical condition, and product availability.
  • Key recommendations emphasize prevention through high-quality, fresh, ABO-compatible platelet preparations, preferably from apheresis, and strategies to prevent anti-HLA alloimmunization.

Impact:

  • Provides critical insights into optimizing platelet transfusion strategies for thrombocytopenia.
  • Aims to improve patient outcomes by reducing transfusion failures.
  • Informs clinical practice and future research in transfusion medicine and hematology.

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...